Clinical trial · Interventional
Postoperative Enteral Immunonutrition in Gastric Cancer
The Impact of Postoperative Enteral Immunonutrition on Postoperative Complications and Survival in Gastric Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Immunomodulating enteral nutrition in the perioperative period may reduce postoperative complications in cancer patients. Little is known if this effect translates to the better survival. The aim of study was to assess the impact of postoperative immunomodulating enteral nutrition on postoperative complications and survival of gastric cancer patients. The group of 98 gastric cancer patients were randomly assigned for postoperative immunomodulating enteral nutrition n=44 (Reconvan ,Fresenius Kabi), or standard enteral nutrition n=54 (Peptisorb, Nutricia). Postoperative complications, mortality, 6-month, 1-year and 5-year survival were analyzed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Immunomodulating nutrition (Reconvan) | Dietary Supplement | — | UNRESOLVED |
| Standard nutrition (Peptisorb) | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Study group
- description
- Immunomodulating nutrition (Reconvan)
- interventionNames
- Dietary Supplement: Immunomodulating nutrition (Reconvan)
- type
- ACTIVE_COMPARATOR
- label
- Control group
- description
- Standard nutrition (Peptisorb)
- interventionNames
- Dietary Supplement: Standard nutrition (Peptisorb)
Primary outcomes (1)
- measure
- Postoperative complication rate
- timeFrame
- 30 days
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * gastric cancer confirmed in histopathological examination * elective operation due to gastric cancer * informed consent signed * age \> 18 years * normal nutritional status or mild to moderate malnutrition Exclusion Criteria: * severe malnutrition which required parenteral nutrition * urgent operation
References
Publications (1)
- RESULTScislo L, Pach R, Nowak A, Walewska E, Gadek M, Brandt P, Puto G, Szczepanik AM, Kulig J. The Impact of Postoperative Enteral Immunonutrition on Postoperative Complications and Survival in Gastric Cancer Patients - Randomized Clinical Trial. Nutr Cancer. 2018 Apr;70(3):453-459. doi: 10.1080/01635581.2018.1445770. Epub 2018 Mar 13. PMID 29533110